Our Mission
CMH Research and Innovations has the potential to make significant contributions to the development and implementation of precise and precision medicine in cancer. The CMH Research and Innovation’s commitment to patient-centered care, its focus on innovation, and its strong relationships with Hospitals, academic institutions and pharmaceutical companies make it well-positioned to play a leading role in this field.
CMH Research and Innovations can also use technology to support its research and innovations in precise and precision medicine for cancer. For example, the hospital could use machine learning to develop new predictive models and risk assessment tools. CMH Research and Innovations could also use telemedicine to provide remote access to precision medicine services to patients who live in rural or underserved areas. Use genetic sequencing to identify the genetic mutations that are driving a patient's cancer, and then use this information to develop a personalized treatment plan. Use biomarker testing to identify biomarkers that can be used to predict the response of a patient to a specific treatment. Partner with other hospitals and research institutions to conduct clinical trials of new precision medicine therapies for cancer.
